Search research articles
Contact Us
Filters
Showing results (321-330 of 340) with videos related to
Page
of 34
Sort By:
Investigational New Drugs
|
May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
B J Eigl, S North, E Winquist, et al.
Gastroenterology
|
January 12, 2023
F4/80<sup>+</sup>Ly6C<sup>high</sup> Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis
Alice E Shin, Yodit Tesfagiorgis, Frederikke Larsen, et al.
Journal of Medicinal Chemistry
|
February 3, 2015
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2
Kurt G Pike, Jeff Morris, Linette Ruston, et al.
Physical Review Letters
|
April 26, 2018
Observation of the Self-Modulation Instability via Time-Resolved Measurements
M Gross, J Engel, J Good, et al.
The Review of Scientific Instruments
|
August 3, 2011
Design and commissioning of a high magnetic field muon spin relaxation spectrometer at the ISIS pulsed neutron and muon source
J S Lord, I McKenzie, P J Baker, et al.
Journal of Patient-Reported Outcomes
|
June 29, 2018
Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)
Joseph M Unger, Katherine Griffin, Gary W Donaldson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2021
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001
Ursula Wiedermann, Erika Garner-Spitzer, Yee Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma
Rashmi S Goswami, Eshetu G Atenafu, Yali Xuan, et al.
Hospital Pediatrics
|
June 28, 2023
Development of an Approach to Assessing Pediatric Fellows' Transport Medical Control Skills
Ryan J Good, Donald L Boyer, Ashley R Bjorklund, et al.
Academic Pediatrics
|
October 31, 2025
Validity Evidence for a Transport Medical Control Assessment Tool Using Simulated Interfacility Transport Calls
Ryan J Good, Alan Schwartz, Richard Mink, et al.
Page
of 34
Search research articles
Search
Showing results (321-330 of 340) with videos related to
Sort By:
Page
of 34
Investigational New Drugs
|
May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
B J Eigl, S North, E Winquist, et al.
Gastroenterology
|
January 12, 2023
F4/80<sup>+</sup>Ly6C<sup>high</sup> Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis
Alice E Shin, Yodit Tesfagiorgis, Frederikke Larsen, et al.
Journal of Medicinal Chemistry
|
February 3, 2015
Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2
Kurt G Pike, Jeff Morris, Linette Ruston, et al.
Physical Review Letters
|
April 26, 2018
Observation of the Self-Modulation Instability via Time-Resolved Measurements
M Gross, J Engel, J Good, et al.
The Review of Scientific Instruments
|
August 3, 2011
Design and commissioning of a high magnetic field muon spin relaxation spectrometer at the ISIS pulsed neutron and muon source
J S Lord, I McKenzie, P J Baker, et al.
Journal of Patient-Reported Outcomes
|
June 29, 2018
Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)
Joseph M Unger, Katherine Griffin, Gary W Donaldson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2021
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001
Ursula Wiedermann, Erika Garner-Spitzer, Yee Chao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma
Rashmi S Goswami, Eshetu G Atenafu, Yali Xuan, et al.
Hospital Pediatrics
|
June 28, 2023
Development of an Approach to Assessing Pediatric Fellows' Transport Medical Control Skills
Ryan J Good, Donald L Boyer, Ashley R Bjorklund, et al.
Academic Pediatrics
|
October 31, 2025
Validity Evidence for a Transport Medical Control Assessment Tool Using Simulated Interfacility Transport Calls
Ryan J Good, Alan Schwartz, Richard Mink, et al.
Page
of 34